United states Molecular Quality Controls Market expected to grow at a CAGR of 10.9% during 2024-2031 | Top Companies - Bio-Rad Laboratories Inc, F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc

Leander, Texas and Tokyo, Japan - Dec.26.2025
As per DataM intelligence research report" Molecular quality controls market size is estimated to reach at a high CAGR 10.9% during the forecast period 2024-2031." Precision diagnostics and regulatory compliance are fueling demand for molecular quality control solutions.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/molecular-quality-controls-market?prasad

United States: Recent Industry Developments

✅ In December 2025, Thermo Fisher Scientific launched a new multi-analyte control for respiratory virus panels. The control includes targets for Flu A/B, RSV, and SARS-CoV-2 in a single vial. It streamlines QC workflows for high-throughput labs during the winter flu season.

✅ In November 2025, Bio-Rad Laboratories introduced a droplet digital PCR (ddPCR) specific quality control kit. The kit ensures the absolute quantification accuracy required for cell and gene therapy applications. It supports the rigorous quality standards of the booming U.S. biopharma sector.

✅ In October 2025, ZeptoMetrix released a non-infectious control for a new emerging tick-borne pathogen. The control allows labs to validate their assays safely without handling live virus. It improves U.S. diagnostic readiness for vector-borne diseases.

✅ In September 2025, LGC Clinical Diagnostics acquired a specialized manufacturer of NGS reference materials. The acquisition expands their portfolio for oncology and hereditary disease testing. It consolidates the supply chain for advanced molecular diagnostics in the U.S.

Japan: Recent Industry Developments

✅ In December 2025, Sysmex Corporation launched a new molecular QC software integrated with its analyzing platforms. The software automates Levey-Jennings charting and peer group comparison. It reduces manual data entry errors in Japanese clinical laboratories.

✅ In November 2025, Takara Bio released a synthetic DNA control for detecting drug-resistant bacteria. The control helps hospitals screen for superbugs like CRE and MRSA accurately. It supports infection control teams in Japanese healthcare facilities.

✅ In October 2025, Fujirebio introduced a quality control panel for Alzheimer's blood biomarkers. The panel ensures the consistency of testing for amyloid and tau proteins. It is critical for the rollout of new dementia diagnostic tests in Japan.

✅ In September 2025, A Japanese metrology institute collaborated with industry to standardize viral load controls. The project aims to unify testing standards across different molecular platforms. It improves the comparability of test results between Japanese hospitals.

Molecular Quality Controls Market: Drivers
Molecular quality control is becoming crucial in pharmaceuticals, biotechnology, and food industries as compliance and product safety standards tighten globally. Innovations in high-throughput genomics and proteomics improve precision and reproducibility. Automation and advanced analytical tools reduce human error, operational costs, and processing times. Rising demand for biologics and personalized medicine increases the need for rigorous quality checks. Regulatory agencies enforcing stringent standards accelerate adoption of molecular QC solutions. Collaboration between industry and research institutions fosters the development of next-generation testing protocols. Increasing awareness of contamination risks in complex biological systems further drives market growth.

Growing healthcare and biotech investments are expanding opportunities for molecular quality control solutions. Integration with AI and digital platforms enhances accuracy, data tracking, and compliance. Rising demand for early-stage diagnostics, therapeutic monitoring, and clinical trial validation supports market adoption. Innovations in assay development allow for broader applications across multiple molecular targets. Industry partnerships accelerate commercialization of high-performance QC tools. Overall, technological advancements, regulatory enforcement, and industry growth position molecular quality control as a critical component of modern biotechnology and pharmaceutical manufacturing.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/molecular-quality-controls-market?prasad

Molecular Quality Controls Market: Major Players
Bio-Rad Laboratories Inc F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc, bioMerieux Inc, and ZeptoMetrix Corporation, Abbott Laboratories, Thermo Fisher Scientific, Microbiologics Inc, Quidel Corporation and Qnostics Ltd.

Segment Covered in the Molecular Quality Controls Market:
By Product Type
The market is segmented into Independent Controls 65% and Instrument-Specific Controls 35%, with independent controls dominating due to their compatibility across multiple platforms, flexibility in laboratory workflows, and cost efficiency. Clinical laboratories prefer independent controls to validate test accuracy across different instruments. Instrument-specific controls are gaining traction with the increasing installation of proprietary molecular diagnostic systems. Growing emphasis on standardization and regulatory compliance supports market growth.

By Application
Applications include Infectious Diseases 40%, Oncology 30%, Genetic Testing 20%, and Others 10%, with infectious disease testing dominating due to high testing volumes for viral, bacterial, and emerging pathogens. Oncology applications show strong growth driven by increasing cancer diagnostics and precision medicine adoption. Genetic testing is expanding with rising demand for prenatal screening and inherited disease testing. Continuous advancements in molecular diagnostics drive application-level adoption.

By End-User
End-users include Clinical Laboratories 55%, IVD Manufacturers & CROs 35%, and Others 10%, with clinical laboratories leading due to routine use of quality controls in molecular testing workflows. IVD manufacturers and CROs rely on molecular quality controls during assay development, validation, and regulatory submissions. Growing outsourcing of diagnostic R&D supports demand from CROs. Increasing test accuracy requirements drive end-user adoption.

Regional Analysis
North America - 40% Share
North America leads with 40% share, supported by advanced diagnostic infrastructure, high adoption of molecular testing, and strong regulatory frameworks in the US and Canada. Infectious disease and oncology testing dominate applications. Clinical laboratories are the primary end-users. Continuous investment in precision medicine and diagnostics supports market growth.

Europe - 25% Share
Europe accounts for 25% share, driven by expanding molecular diagnostics in healthcare systems across Germany, the UK, and France. Oncology and genetic testing are key growth areas. Independent quality controls dominate due to multi-platform laboratory setups. Strong regulatory compliance requirements support steady market expansion.

Asia Pacific - 20% Share
Asia Pacific holds 20% share, supported by increasing healthcare expenditure, rising infectious disease burden, and expanding diagnostic laboratories in China, India, and Japan. Infectious disease testing leads demand. Growing awareness of quality assurance in diagnostics drives market growth.

Latin America - 10% Share
Latin America records 10% share, driven by improving laboratory infrastructure and increasing molecular diagnostic adoption in Brazil and Mexico. Infectious disease applications dominate. Clinical laboratories are the key end-users. Government healthcare investments support gradual market growth.

Middle East & Africa - 5% Share
Middle East & Africa account for 5% share, supported by expanding diagnostic capacity and infectious disease testing programs. Independent controls dominate due to flexibility across platforms. Growing healthcare modernization initiatives drive market expansion.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=molecular-quality-controls-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.